[Prevention of influenza in pregnant women and neonatal infants].
The review presents the data available in the literature on the incidence of influenza, postinfluenza complications, hospitalizations, and deaths in pregnant women, on the negative fetal and neonatal impact of this disease in pregnant women, on vaccination of pregnant women with inactivated influenza vaccines. It also gives data on the high rates of influenza complications, admissions, and death in the newborns and on possible prevention of neonatal influenza at the expense of maternal antibodies. It is concluded that it is expedient to vaccinate pregnant women against influenza to reduce the rates of morbidity, hospitalization, and mortality due to influenza infection among both women themselves and neonatal infants.
Gendon
Iu Z
IuZ
D005260:Female; D014943:Global Health; D006760:Hospitalization / Q000706:statistics & numerical data; D006801:Humans; D007112:Immunity, Maternally-Acquired / Q000276:immunology; D015994:Incidence; D007223:Infant; D007231:Infant, Newborn; D007252:Influenza Vaccines / Q000627:therapeutic use*; D007251:Influenza, Human / Q000453:epidemiology* / Q000276:immunology / Q000517:prevention & control*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000453:epidemiology* / Q000517:prevention & control* / Q000821:virology; D014611:Vaccination
D007252:Influenza Vaccines